Singapore Hepatology Conference (SHC) 2017
In-Person Event
Jun 02 - 03, 2017
Singapore, Singapore, SGOVERVIEW
Singapore Hepatology Conference (SHC) is organized by Singapore Hepatitis Conference Pte Ltd and would be held during Jun 02 - 03, 2017 at Suntec Singapore Convention & Exhibition Centre, Singapore.
SHC 2017 will be expanded to include topics such as liver cancer, cirrhosis and fatty liver due to an increase in requests for a broader conference. There has been increasing interest in HBV Cure, and after discussion with ICE-HBV and EASL, SHC 2017 will introduce a parallel track – the “Science of HBV Cure”. Consequently, the Conference has been renamed as Singapore Hepatology Conference.
SHC will to focus on HCV and HBV treatment and difficult to treat areas. The clinical meeting will continue with updates, case discussion and expert forums, a highly successful, interactive and engaging format that has been used the last 3 years.
The European Association for the Study of the Liver (EASL) has partnered with SHC since 2015 and will continue to support SHC on an even stronger collaboration for the 2017 meeting.
The 3rd Singapore Hepatitis Conference and the best of EASL (SHC-EASL) 2016 was an outstanding success with over 400 participants from 26 countries. The conference also featured 22 internationally renowned speakers and consisted of plenary sessions, case discussions, debates and poster presentations. . The scientific programme provided a multi-disciplinary approach to the assessment, diagnosis and treatment strategies to eradicate HBV and HCV.
The 2017 Conference has the following exciting Topic Highlights:
• Evolving HBV therapy - combination and stopping NA
• Future treatments for HBV
• HCC debate: East vs West
• DAA difficult to treat cases
• DAA treatment failures and resistance
• HCC immunotherapy
• Fatty liver disease in Asia
• Therapeutic advances in NASH.
SHC 2017 will be expanded to include topics such as liver cancer, cirrhosis and fatty liver due to an increase in requests for a broader conference. There has been increasing interest in HBV Cure, and after discussion with ICE-HBV and EASL, SHC 2017 will introduce a parallel track – the “Science of HBV Cure”. Consequently, the Conference has been renamed as Singapore Hepatology Conference.
SHC will to focus on HCV and HBV treatment and difficult to treat areas. The clinical meeting will continue with updates, case discussion and expert forums, a highly successful, interactive and engaging format that has been used the last 3 years.
The European Association for the Study of the Liver (EASL) has partnered with SHC since 2015 and will continue to support SHC on an even stronger collaboration for the 2017 meeting.
The 3rd Singapore Hepatitis Conference and the best of EASL (SHC-EASL) 2016 was an outstanding success with over 400 participants from 26 countries. The conference also featured 22 internationally renowned speakers and consisted of plenary sessions, case discussions, debates and poster presentations. . The scientific programme provided a multi-disciplinary approach to the assessment, diagnosis and treatment strategies to eradicate HBV and HCV.
The 2017 Conference has the following exciting Topic Highlights:
• Evolving HBV therapy - combination and stopping NA
• Future treatments for HBV
• HCC debate: East vs West
• DAA difficult to treat cases
• DAA treatment failures and resistance
• HCC immunotherapy
• Fatty liver disease in Asia
• Therapeutic advances in NASH.
KEY DATES
02 Jun, 2017
Event Start Date
03 Jun, 2017
Event End Date
SPECIALITIES
HepatologySUGGESTED HOTELS
CONFERENCE VENUE
Suntec Singapore International Convention and Exhibition CentreRELATED CONFERENCES & LIVE WEBINARS
Quick Links